We are live on ! Find out more
CRDL

Cardiol Therapeutics
CRDL

41 hedge funds and large institutions have $9.85M invested in Cardiol Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

782% more call options, than puts

Call options by funds: $194K | Put options by funds: $22K

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

0% more funds holding

Funds holding: 41 → 41 (0)

0.7% less ownership

Funds ownership: 7.81% → 7.12% (-0.7%)

9% less capital invested

Capital invested by funds: $10.8M → $9.85M (-$981K)

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

Holders
41
Holders Change
–
Holders Change %
0%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
10
Closed
9
Calls
$194K
Puts
$22K
Net Calls
+$172K
Net Calls Change
-$707K

Top Buyers

Rank Fund Capital Flow
1
FIA
Foundations Investment Advisors
Arizona
+$236K
2
TC
Tejara Capital
United Kingdom
+$102K
3
Morgan Stanley
Morgan Stanley
New York
+$75.5K
4
WANY
Wealthspire Advisors (New York)
New York
+$62.9K
5
Two Sigma Investments
Two Sigma Investments
New York
+$51.2K

Top Sellers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
-$614K
2
MI
MMCAP International
Cayman Islands
-$267K
3
LNWTC
Laird Norton Wetherby Trust Company
Washington
-$202K
4
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$114K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$84.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$12.3K -$41.4K -19,966 -76%
PSB
27
Piscataqua Savings Bank
New Hampshire
$10.3K – – –
VNA
28
Valley National Advisers
Pennsylvania
$9K – – –
Bank of America
29
Bank of America
North Carolina
$7.92K – – –
HFM
30
Hartford Financial Management
Connecticut
$7.92K – – –
UBS Group
31
UBS Group
Switzerland
$5.25K +$311 +150 +6%
JP Morgan Chase
32
JP Morgan Chase
New York
$4.95K +$5.19K +2,500 New
Wells Fargo
33
Wells Fargo
California
$3.98K -$2.08K -1,000 -33%
Osaic Holdings
34
Osaic Holdings
Arizona
$2.38K – – –
RA
35
Rise Advisors
New York
$1.98K – – –
SC
36
SouthState Corp
Florida
$1.98K – – –
PPA
37
Painted Porch Advisors
California
$990 – – –
CTC
38
Central Trust Company
Missouri
$792 +$830 +400 New
HNB
39
Huntington National Bank
Ohio
$477 +$500 +241 New
National Bank of Canada
40
National Bank of Canada
Quebec, Canada
$400 -$3.73K -1,798 -90%
SHIM
41
Stone House Investment Management
Pennsylvania
$99 – – –
LNWTC
42
Laird Norton Wetherby Trust Company
Washington
– -$202K -100,000 Closed
Arrowstreet Capital
43
Arrowstreet Capital
Massachusetts
– -$58K -29,294 Closed
BBA
44
Baader Bank Aktiengesellschaft
Germany
– -$34.4K -29,028 Closed
Envestnet Asset Management
45
Envestnet Asset Management
Illinois
– -$52.5K -26,167 Closed
AI
46
Atria Investments
North Carolina
– -$22.6K -11,165 Closed
Verition Fund Management
47
Verition Fund Management
Connecticut
– -$22.4K -11,109 Closed
CIBC Private Wealth Group
48
CIBC Private Wealth Group
Georgia
– -$15K -8,000 Closed
BEI
49
Benjamin Edwards Inc
Missouri
– -$2K -875 Closed
Toronto Dominion Bank
50
Toronto Dominion Bank
Ontario, Canada
– -$1.62K -803 Closed
1
2

CRDL Hedge Fund Activity: Q3 2024 in Review

41 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cardiol Therapeutics (CRDL) for Q3 2024, worth a combined $9.85M — down 9.1% from $10.8M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CRDL positions and 9 closed out — a net gain of 1 holder — while 6 added to existing stakes and 10 trimmed.

The largest buyer was Foundations Investment Advisors, adding an estimated $236K. The largest seller was AdvisorShares Investments, cutting an estimated $614K.

  • 41 institutional investors held Cardiol Therapeutics (CRDL) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $9.85M of Cardiol Therapeutics stock for Q3 2024, down 9.1% quarter-over-quarter.
  • 10 funds opened new Cardiol Therapeutics positions in Q3 2024 and 9 closed out, a net change of +1 holder.
  • The largest Cardiol Therapeutics buyer in Q3 2024 was Foundations Investment Advisors, an estimated $236K added.
  • The largest Cardiol Therapeutics seller in Q3 2024 was AdvisorShares Investments, an estimated $614K sold.

Based on aggregated 13F filings for Q3 2024.